What is Caplin Point Laboratories Book Value per Share?
Caplin Point Laboratories's book value per share for the quarter that ended in Mar. 2024 was ₹304.93.
During the past 12 months, Caplin Point Laboratories's average Book Value Per Share Growth Rate was 23.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 27.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 30.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 45.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Caplin Point Laboratories was 67.00% per year. The lowest was 10.40% per year. And the median was 37.95% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Caplin Point Laboratories Book Value per Share Chart
Competitive Comparison of Caplin Point Laboratories's Book Value per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caplin Point Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's PB Ratio distribution charts can be found below:
* The bar in red indicates where Caplin Point Laboratories's PB Ratio falls into.
Caplin Point Laboratories Book Value per Share Calculation
Caplin Point Laboratories's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Caplin Point Laboratories (BOM:524742) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Caplin Point Laboratories Book Value per Share Related Terms
Thank you for viewing the detailed overview of Caplin Point Laboratories's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Caplin Point Laboratories (BOM:524742) Business Description
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524742 has been successfully added to your 